PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 176 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,360,000 | -51.4% | 307,737 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $2,800,000 | -64.4% | 307,737 | -20.0% | 0.00% | -60.0% |
| Q4 2021 | $7,868,000 | -29.9% | 384,541 | -12.5% | 0.01% | -37.5% |
| Q3 2021 | $11,224,000 | -27.3% | 439,313 | -0.5% | 0.01% | -33.3% |
| Q2 2021 | $15,435,000 | +5.3% | 441,380 | +0.3% | 0.01% | +9.1% |
| Q1 2021 | $14,659,000 | +27.2% | 440,088 | -1.0% | 0.01% | +22.2% |
| Q4 2020 | $11,526,000 | +209.3% | 444,345 | +17.7% | 0.01% | +200.0% |
| Q3 2020 | $3,727,000 | +237.0% | 377,643 | +17.7% | 0.00% | +200.0% |
| Q2 2020 | $1,106,000 | +14.3% | 320,724 | +1.4% | 0.00% | 0.0% |
| Q1 2020 | $968,000 | -41.1% | 316,424 | -1.0% | 0.00% | 0.0% |
| Q4 2019 | $1,643,000 | +25.8% | 319,724 | +26.4% | 0.00% | 0.0% |
| Q3 2019 | $1,306,000 | +10.9% | 253,024 | +30.0% | 0.00% | 0.0% |
| Q2 2019 | $1,178,000 | -65.6% | 194,642 | -58.9% | 0.00% | -75.0% |
| Q1 2019 | $3,424,000 | +4.7% | 473,605 | +7.2% | 0.00% | -20.0% |
| Q4 2018 | $3,270,000 | +36.8% | 441,883 | 0.0% | 0.01% | +66.7% |
| Q3 2018 | $2,391,000 | +47.2% | 441,883 | -3.4% | 0.00% | +50.0% |
| Q2 2018 | $1,624,000 | +73.1% | 457,400 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $938,000 | -22.4% | 457,400 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $1,208,000 | -49.7% | 457,400 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $2,401,000 | +47.5% | 457,400 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $1,628,000 | +51.7% | 457,400 | +120.4% | 0.00% | +50.0% |
| Q1 2017 | $1,073,000 | +30.4% | 207,500 | -4.2% | 0.00% | +100.0% |
| Q4 2016 | $823,000 | -59.7% | 216,500 | -4.9% | 0.00% | -66.7% |
| Q3 2016 | $2,040,000 | +19.2% | 227,700 | -6.4% | 0.00% | 0.0% |
| Q2 2016 | $1,712,000 | -19.7% | 243,300 | -3.0% | 0.00% | 0.0% |
| Q1 2016 | $2,133,000 | -39.0% | 250,900 | -5.7% | 0.00% | -50.0% |
| Q4 2015 | $3,494,000 | +258.7% | 266,100 | 0.0% | 0.01% | +200.0% |
| Q3 2015 | $974,000 | -38.5% | 266,100 | -3.3% | 0.00% | 0.0% |
| Q2 2015 | $1,584,000 | -30.3% | 275,050 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $2,272,000 | 0.0% | 275,050 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,272,000 | +68.3% | 275,050 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $1,350,000 | -20.6% | 275,050 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,700,000 | +35.4% | 275,050 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,256,000 | -50.9% | 275,050 | -45.4% | 0.00% | -50.0% |
| Q4 2013 | $2,558,000 | -8.4% | 503,600 | -0.3% | 0.00% | -20.0% |
| Q3 2013 | $2,793,000 | +119.4% | 505,000 | 0.0% | 0.01% | +66.7% |
| Q2 2013 | $1,273,000 | – | 505,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |